Biological Drugs Market - a Well-Defined Technological Growth Map with an Impact-Analysis
The 2013 Biologics Report on pharma.org states that many biopharmaceutical research companies in America are utilizing biological processes to create 907 medicines and vaccines aimed at more than 100 diseases. At present, several biological drugs are in the pipeline for auto-immune diseases, blood diseases, cancer-related conditions, and diabetes and cardiovascular diseases. The global biological drugs market is marked by robust R&D efforts. Companies in the global biological drugs market are investing millions to boost their R&D efforts to create revolutionary...
View full press release